Filtros de búsqueda

Lista de obras de

A change of heart

artículo científico publicado en 2009

A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial

artículo científico publicado en 2017

A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference

artículo científico publicado en 2015

ACP Journal Club. Defibrillator therapy improved quality of life in CHF; amiodarone did not.

artículo científico publicado en 2009

Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation

artículo científico publicado en 2016

Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke

artículo científico publicado en 2014

Alternative calculations of individual patient time in therapeutic range while taking warfarin: results from the ROCKET AF trial

artículo científico publicado en 2015

Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials

scientific article published on 31 March 2009

Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction

artículo científico publicado en 2011

Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease

artículo científico publicado en 2014

Anticoagulation and Clinical Outcomes in Heart Failure Patients With Atrial Fibrillation: Findings From the ADHERE Registry

artículo científico publicado en 2013

Anticoagulation in atrial fibrillation

artículo científico publicado en 2014

Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients

artículo científico publicado en 2012

Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician

artículo científico publicado en 2008

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

artículo científico publicado en 2018

Arrhythmogenic right ventricular dysplasia: a United States experience

artículo científico publicado en 2005

Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

artículo científico publicado en 2015

Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery

artículo científico publicado en 2018

Association of Atrial Fibrillation Clinical Phenotypes with Treatment Patterns and Outcomes: A Multicenter Registry Study

artículo científico publicado en 2017

Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation

Associations between anticoagulation therapy and risks of mortality and readmission among patients with heart failure and atrial fibrillation

artículo científico publicado en 2014

Atrial Fibrillation Complicating Acute Coronary Syndromes

scientific article published on 06 October 2012

Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors

artículo científico publicado en 2013

Atrial fibrillation and stroke: It's not necessarily all about the rhythm ⬇️

artículo científico publicado el 10 de mayo de 2011

Atrial fibrillation in heart failure: what should we do?

artículo científico publicado en 2015

Atrioventricular and ventricular-to-ventricular programming in patients with cardiac resynchronization therapy: results from ALTITUDE

artículo científico publicado en 2015

Autonomic Modulation for the Treatment of Ventricular Arrhythmias: Therapeutic Use of Percutaneous Stellate Ganglion Blocks

artículo científico publicado en 2016

Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: Results from the ROCKET AF Trial

artículo científico publicado en 2016

Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure

artículo científico

Cable externalization and electrical failure of the Riata family of implantable cardioverter-defibrillator leads: A systematic review and meta-analysis

artículo científico

Calcified Pipes: You Better Call the Electrician Too.

artículo científico publicado en 2015

Cardiac conduction system disease after transcatheter aortic valve replacement ⬇️

artículo científico publicado el 2 de octubre de 2012

Cardiac implantable electronic device removal in patients with left ventricular assist device associated infections

artículo científico publicado en 2014

Cardioversion and subsequent quality of life and natural history of atrial fibrillation

artículo científico publicado en 2016

Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.

artículo científico publicado en 2017

Cases from the Osler Medical Service at Johns Hopkins University. Diffuse colonic angiodysplasia with chronic iron deficiency anemia

artículo científico publicado en 2003

Cases from the Osler Medical Service at Johns Hopkins University. Digitalis toxicity with bidirectional ventricular tachycardia

scientific article published on 01 July 2003

Cases from the Osler Medical Service at Johns Hopkins University. Zieve syndrome

artículo científico publicado en 2003

Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

artículo científico publicado en 2015

Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction

artículo científico publicado en 2017

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

artículo científico publicado en 2016

Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry

artículo científico publicado en 2016

Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy

article

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial

artículo científico publicado en 2014

Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke

artículo científico publicado en 2013

Clinical effectiveness of cardiac resynchronization therapy versus medical therapy alone among patients with heart failure: analysis of the ICD Registry and ADHERE

artículo científico publicado en 2014

Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2

artículo científico publicado en 2006

Cognitive dysfunction in atrial fibrillation

scientific article published on 01 December 2018

Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry

artículo científico publicado en 2016

Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study

artículo científico publicado en 2014

Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery

artículo científico publicado en 2013

Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation

artículo científico publicado en 2009

Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry

Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease

artículo científico publicado en 2014

Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs

artículo científico publicado en 2015

Completion of guideline-recommended initial evaluation of atrial fibrillation

artículo científico publicado en 2012

Contraindications to anticoagulation therapy and eligibility for novel anticoagulants in older patients with atrial fibrillation

artículo científico publicado en 2015

Cryoablation of atrial fibrillation

artículo científico

Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative

artículo científico publicado en 2009

Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies ⬇️

artículo científico publicado el 24 de julio de 2013

Device Therapy in Heart Failure Patients With Chronic Kidney Disease ⬇️

artículo científico publicado el 23 de agosto de 2011

Diagnostic monitoring strategies in heart failure management

artículo científico publicado en 2007

Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry

artículo científico

Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort

artículo científico publicado en 2015

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tr

artículo científico publicado en 2015

Disease understanding in patients newly diagnosed with atrial fibrillation

artículo científico publicado en 2017

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)

artículo científico publicado en 2014

Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation

artículo científico publicado en 2013

Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

artículo científico publicado en 2018

Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF]).

artículo científico publicado en 2017

Effect of the 2014 atrial fibrillation guideline revisions on the proportion of patients recommended for oral anticoagulation

artículo científico publicado en 2015

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).

artículo científico publicado en 2017

Efficacy and Safety of Rivaroxaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation and a History of Cancer: Observations from ROCKET AF

article by Sean T Chen et al published 14 September 2018 in European heart journal. Quality of care & clinical outcomes

Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Em

artículo científico publicado en 2014

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF.

artículo científico publicado en 2013

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial F

article by Sameer Bansilal et al published October 2015 in American Heart Journal

Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial

artículo científico

Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials ⬇️

artículo científico publicado el 30 de octubre de 2010

Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association

artículo científico publicado en 2016

End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience

artículo científico publicado en 2013

Evolving Role of Multidetector Computed Tomography in Evaluation of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

scholarly article by Chandra Bomma et al published July 2007 in American Journal of Cardiology

Exercise training and implantable cardioverter-defibrillator shocks in patients with heart failure: results from HF-ACTION (Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing)

artículo científico publicado en 2013

Exercise training and pacing status in patients with heart failure: results from HF-ACTION.

artículo científico publicado en 2014

Extent of and Reasons for Nonuse of Implantable Cardioverter Defibrillator Devices in Clinical Practice Among Eligible Patients With Left Ventricular Systolic Dysfunction ⬇️

artículo científico publicado el 8 de febrero de 2011

Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation).

artículo científico publicado en 2013

Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).

artículo científico publicado en 2017

Familial clustering and subsequent incidence of atrial fibrillation among first-degree relatives in Denmark

artículo científico publicado en 2015

Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

artículo científico publicado en 2016

Feedback to providers improves evidence-based implantable cardioverter-defibrillator programming and reduces shocks

artículo científico publicado en 2014

For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding ⬇️

artículo científico publicado el 18 de febrero de 2012

Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).

artículo científico publicado en 2018

Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.

artículo científico publicado en 2015

Gender Differences in Clinical Outcomes after Catheter Ablation of Atrial Fibrillation.

artículo científico publicado en 2016

Geographic variation in the use of catheter ablation for atrial fibrillation among Medicare beneficiaries

artículo científico publicado en 2015

Get With The Guidelines AFIB: novel quality improvement registry for hospitalized patients with atrial fibrillation

artículo científico publicado en 2014

Heart rate is associated with progression of atrial fibrillation, independent of rhythm

artículo científico publicado en 2015

High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction

artículo científico publicado en 2015

High-density mapping of the tachycardia circuit in atrioventricular nodal reentrant tachycardia

artículo científico publicado en 2016

Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial

artículo científico publicado en 2014

Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF

artículo científico publicado en 2016

How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

artículo científico publicado en 2016

Impact of Tachyarrhythmia Detection Rate and Time from Detection to Shock on Outcomes in Nationwide US Practice

artículo científico publicado en 2017

Impact of Using a Telescoping‐Support Catheter System for Left Ventricular Lead Placement on Implant Success and Procedure Time of Cardiac Resynchronization Therapy ⬇️

artículo científico publicado el 25 de febrero de 2013

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial

artículo científico publicado en 2013

Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

artículo científico publicado en 2015

Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF

article by Sean T. Chen et al published June 2018 in American Heart Journal

Impact of remote monitoring on clinical events and associated health care utilization: A nationwide assessment

artículo científico publicado en 2016

Implantable Cardioverter-Defibrillators in Patients Hospitalized for Heart Failure With Chronically Reduced Left Ventricular Ejection Fraction

Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions

artículo científico publicado en 2011

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation

artículo científico publicado en 2017

Improved survival in patients enrolled promptly into remote monitoring following cardiac implantable electronic device implantation

artículo científico publicado en 2016

Improving outcomes after catheter ablation of atrial fibrillation: better patient selection, better procedure, or both?

artículo científico publicado en 2017

Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.

artículo científico publicado en 2012

Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)

artículo científico publicado en 2015

Influence of Kidney Function Estimation Methods on Eligibility for Edoxaban Population Impact of the US Food and Drug Administration's Approach for Its Product Labeling

artículo científico publicado en 2016

Insulin Therapy and Stroke Risk in Patients With Diabetes and Atrial Fibrillation: Guilty by Association?

artículo científico publicado en 2017

International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries

artículo científico publicado en 2017

International variation in use of oral anticoagulation among heart failure patients with atrial fibrillation

artículo científico publicado en 2012

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban

article

Intraoperative Magnesium Administration Does Not Reduce Postoperative Atrial Fibrillation After Cardiac Surgery

artículo científico publicado en 2015

Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial

scientific article published on 15 October 2013

Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

artículo científico publicado en 2014

Left Atrial Appendage Closure

artículo científico publicado en 2018

Left Atrial Appendage Electrical Isolation for Treatment of Recurrent Atrial Fibrillation: A Meta-Analysis

artículo científico publicado en 2017

Left Atrial Remodeling: Shape Before Size? ⬇️

artículo científico publicado el 9 de abril de 2013

Left atrial appendage occlusion: rationale, evidence, devices, and patient selection

artículo científico publicado en 2016

Localization of pacing and defibrillator leads using standard x-ray views is frequently inaccurate and is not reproducible

artículo científico publicado en 2015

Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research Consortium

artículo científico publicado en 2017

Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry

artículo científico

Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial F

artículo científico publicado en 2017

Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association

artículo científico publicado en 2017

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial

artículo científico publicado en 2014

Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry

scientific article published on 18 December 2013

Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry

artículo científico publicado en 2018

Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

artículo científico publicado en 2010

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

artículo científico publicado en 2016

Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF.

artículo científico publicado en 2018

New insights into diastolic heart failure: role of diabetes mellitus

artículo científico publicado en 2004

Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.

artículo científico publicado en 2016

Novel mechanism of premature battery failure due to lithium cluster formation in implantable cardioverter-defibrillators

artículo científico publicado en 2014

Obstructive sleep apnea is associated with increased rotor burden in patients undergoing focal impulse and rotor modification guided atrial fibrillation ablation.

artículo científico publicado en 2017

Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes: The ORBIT-AF II Registry

artículo científico publicado en 2016

On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.

artículo científico

Optimal Utilization and Management of Implanted Cardiac Rhythm Devices in Patients Hospitalized for Heart Failure ⬇️

artículo científico publicado el 5 de junio de 2013

Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis

artículo científico publicado en 2014

Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?

artículo científico publicado en 2017

Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation

artículo científico publicado en 2017

Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation

artículo científico publicado en 2010

Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial i

Outcomes Associated With Familial Versus Nonfamilial Atrial Fibrillation: A Matched Nationwide Cohort Study

artículo científico publicado en 2016

Outcomes Associated with Extraction versus Capping and Abandoning Pacing and Defibrillator Leads

artículo científico publicado en 2017

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry

artículo científico publicado en 2014

Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial

artículo científico publicado en 2013

Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation

artículo científico publicado en 2012

Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Preven

artículo científico publicado en 2013

Outcomes of medicare beneficiaries with heart failure and atrial fibrillation

artículo científico publicado en 2014

Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention o

artículo científico publicado en 2014

Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.

artículo científico publicado en 2011

Patient factors associated with quality of life in atrial fibrillation

artículo científico publicado en 2016

Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry

artículo científico publicado en 2015

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation

artículo científico publicado en 2015

Periprocedural Anticoagulation Management for Atrial Fibrillation Ablation: Current Knowledge and Future Directions

artículo científico publicado en 2018

Periprocedural imaging and outcomes after catheter ablation of atrial fibrillation

artículo científico publicado en 2014

Pharmacogenomics of Bucindolol in Atrial Fibrillation and Heart Failure

artículo científico publicado en 2017

Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF

scientific article published on 01 September 2018

Pharmacotherapy in Medicare beneficiaries with atrial fibrillation ⬇️

artículo científico publicado el 24 de abril de 2012

Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

artículo científico publicado en 2014

Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation

artículo científico

Postmarket surveillance and returned product analysis: Success but not transparency ⬇️

artículo científico publicado el 3 de agosto de 2013

Predicting AF recurrence after catheter ablation: Is it time to use the force?

artículo científico publicado en 2018

Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation

artículo científico publicado en 2017

Predictors and progression of aortic stenosis in patients with preserved left ventricular ejection fraction

artículo científico publicado en 2014

Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia

artículo científico publicado en 2005

Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy ⬇️

artículo científico publicado el 6 de agosto de 2011

Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial

artículo científico publicado en 2009

Preprocedural ECG-gated computed tomography for prevention of complications during lead extraction

artículo científico publicado en 2014

Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).

artículo científico publicado en 2017

Preventing Stroke in Patients With Atrial Fibrillation-A Steep Climb Away From Achieving Peak Performance

artículo científico publicado en 2016

Prognostic validation of an algorithm to convert myocardial perfusion SPECT imaging data from a 12-segment model to a 17-segment model

artículo científico publicado en 2009

Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.

artículo científico publicado en 2014

Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia

artículo científico publicado en 2010

Provider specialty and atrial fibrillation treatment strategies in United States community practice: findings from the ORBIT-AF registry

artículo científico publicado en 2013

QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy

artículo científico publicado en 2013

Quality of Evidence Underlying the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines on the Management of Atrial Fibrillation

artículo científico publicado en 2016

Quality of care for atrial fibrillation among patients hospitalized for heart failure

artículo científico publicado en 2009

Racial differences in the prevalence and outcomes of atrial fibrillation among patients hospitalized with heart failure ⬇️

scientific article published on 26 September 2013

Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry

artículo científico publicado en 2015

Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR.

artículo científico publicado en 2016

Ranolazine reduces atrial fibrillatory wave frequency

artículo científico publicado en 2016

Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry

artículo científico publicado en 2013

Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation

artículo científico publicado en 2017

Rationale and design of the Duke Electrophysiology Genetic and Genomic Studies (EPGEN) biorepository

artículo científico publicado en 2009

Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

artículo científico publicado en 2014

Recent Advances in Lesion Formation for Catheter Ablation of Atrial Fibrillation

artículo científico publicado en 2016

Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention o

Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIA

artículo científico publicado en 2008

Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial

artículo científico publicado en 2014

Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk

Remote monitoring of cardiac implantable electronic devices (CIED).

artículo científico publicado en 2016

Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin

artículo científico

Reply to the Editor- Contact force-sensing catheters and increased risk of atrioesophageal fistula: Is the tool to blame or the workmen?

artículo científico publicado en 2017

Reply: Graphing Ratio Measures on Forest Plot

artículo científico publicado en 2018

Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".

artículo científico publicado en 2016

Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Fac

article by Jonathan P Piccini et al published 10 September 2013 in Circulation

Retrograde ascending aortic dissection as an early complication of thoracic endovascular aortic repair

artículo científico publicado en 2012

Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation

Rhythm control in atrial fibrillation

artículo científico publicado en 2016

Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation

artículo científico publicado en 2014

Risk of atrioesophageal fistula formation with contact force-sensing catheters

artículo científico publicado en 2017

Risks and Benefits of Anticoagulation in Atrial Fibrillation

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease

artículo científico publicado en 2016

Safety and Efficacy of Exercise Training in Patients With an Implantable Cardioverter-Defibrillator

Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial

artículo científico

Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction

artículo científico publicado en 2012

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration

artículo científico publicado en 2017

Single vs. dual chamber implantable cardioverter-defibrillators or programming of implantable cardioverter-defibrillators in patients without a bradycardia pacing indication: systematic review and meta-analysis

artículo científico publicado en 2018

Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction>35%.

artículo científico publicado en 2010

Sinus Node Dysfunction Is Associated With Higher Symptom Burden and Increased Comorbid Illness: Results From the ORBIT-AF Registry

artículo científico publicado en 2015

Sinus Node Dysfunction and Atrial Fibrillation: A Reversible Phenomenon?

artículo científico publicado en 2017

Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy

artículo científico publicado en 2016

Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHADS-VASc Scores: Findings From the ORBIT-AF I and II Registries

article published in 2018

Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

artículo científico publicado en 2016

Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trials

scientific article published on October 2010

Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials

artículo científico publicado en 2013

Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort

artículo científico publicado en 2017

Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes

artículo científico

The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation

artículo científico publicado en 2015

The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients

artículo científico publicado en 2015

The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fraction

artículo científico publicado en 2011

The potential role of nonpharmacologic electrophysiology-based interventions in improving outcomes in patients hospitalized for heart failure

artículo científico

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AF.

artículo científico publicado en 2018

Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atr

artículo científico publicado en 2017

Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).

artículo científico publicado en 2017

Treatment of atrial fibrillation in East Asia: what is perception and what is reality?

artículo científico publicado en 2014

Triple Therapy for Atrial Fibrillation after PCI.

artículo científico publicado en 2017

Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease

artículo científico publicado en 2016

Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry

artículo científico publicado en 2013

Use and outcomes associated with bridging during anticoagulation interruptions in patients with atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

artículo científico publicado en 2014

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial

artículo científico publicado en 2014

Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation

artículo científico publicado en 2018

Use of Preprocedural MDCT for Cardiac Implantable Electric Device Lead Extraction: Frequency of Findings That Change Management

artículo científico publicado en 2017

Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease

artículo científico publicado en 2014

Use of cardiac resynchronization therapy in patients hospitalized with heart failure

artículo científico publicado en 2008

Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial

artículo científico publicado en 2016

Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillation

artículo científico publicado en 2013

Validation of non-contact and point-to-point mapping in a single electroanatomic map.

artículo científico publicado en 2013

Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy

artículo científico publicado en 2013

Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association

artículo científico publicado en 2016

Why develop antidotes and reversal agents for non-vitamin K oral anticoagulants?

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda